MedPath
FDA Approval

iwilfin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
USWM, LLC
DUNS: 117542566
Effective Date
December 21, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Eflornithine(250 mg in 1 1)

Manufacturing Establishments5

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

CoreRx Pharmaceuticals, Inc.

USWM, LLC

780516717

SGS North America

USWM, LLC

808308303

Aphena Pharma Solutions - TN, LLC

USWM, LLC

118348161

ScinoPharm Taiwan Ltd.

USWM, LLC

657484726

Quality Chemical Laboratories

USWM, LLC

071344167

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

iwilfin

Product Details

NDC Product Code
78670-150
Application Number
NDA215500
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
December 21, 2023
Code: 4NH22NDW9HClass: ACTIRQuantity: 250 mg in 1 1
microcrystalline celluloseInactive
Code: OP1R32D61UClass: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath